Recovery International Co.,Ltd.

9214.T
Medical Care Facilities
2026/11/20 20:23 Updated
Market Cap: $10.8M (¥1.7B)
Stock Price: $8.28 (¥1,315)
Exchange Rate: 1 USD = ¥158.73

Notice Regarding Commencement of New Business

Commencement of development and provision of C+Route, an AI scheduling system specialized for home-visit nursing, as a new business. The notice presents the business purpose, overview, and cost outlook. The immediate impact on future results is expected to be minor, but it is anticipated to contribute to revenue base diversification over the medium to long term.

Importance:
Page Updated: November 18, 2026
IR Disclosure Date: November 18, 2026

Key Figures

  • Estimated additional expenditures for development, advertising and personnel: Expected to exceed 10% of the consolidated carrying amount of fixed assets for the fiscal year ending 2025-12
  • Business start date: 2026-11-18
  • Business commencement date: 2026-11-18

AI要約

Overview of the New Business

The Company will launch C+Route as a new business to solve challenges in the home-visit nursing field using AI. Adopting a BPaaS model, it will operate on a usage-based charge and support operational design through PL improvement. The service aims to reduce administrative burden on-site, promote DX, reduce travel time and increase the number of visits.

Financial Impact and Future Outlook

The Company expects the impact on consolidated results for the current fiscal period from the launch of the new business to be minor; however, in the long term it is expected to contribute to diversification of the revenue base and enhancement of corporate value. Although initial investments have been completed, additional costs are anticipated and are expected to exceed 10% of the consolidated carrying amount of fixed assets for the fiscal year ending 2025-12.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Recovery International Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →